跳至主要内容
临床试验/NCT03591783
NCT03591783Unknown不适用

Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease

Assiut University0 个研究点目标入组 140 人开始时间: 2018年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
140
主要终点
the percentage of patients with glycemic control

研究概览

简要总结

Hepatitis C virus (HCV) is a major cause of chronic liver disease. The World Health Organization has reported that 170 million people are chronically infected with HCV globally. The highest prevalence of HCV infection worldwide exists in Egypt (15%); 90% of infection among Egyptian patients is due to genotype 4

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Chronic HCV infection will be diagnosed based on positive testing for serum HCV RNA and anti-HCV Ab.
  • Diagnosis of type 2 DM will depend on fasting level of serum glucose more than 126 mg/dl and/or serum level of HbA1c more than 6.5 % on oral hypoglycemic therapy.

排除标准

  • Chronic hepatitis due to causes other than HCV infection
  • Coinfection with HBV infection
  • Hepatocellular carcinoma
  • Child C stage of liver cirrhosis.
  • Patients with type I diabetes mellitus.
  • Cardiopulmonary diseases.
  • Major illness.
  • Patient receiving corticosteroids.
  • Patient refused consent.

结局指标

主要结局

the percentage of patients with glycemic control

时间窗: 3 months

Exploring the impact of achieving SVR by directly acting antiviral drugs on glycemic control among diabetic patients with HCV infection.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa Judy

Principal investigator

Assiut University

相似试验

Impact of Sustained Virologic Response on Glycemic... | 临床试验